These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1781 related articles for article (PubMed ID: 25271081)

  • 21. Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma.
    Li T; Qin LX; Gong X; Zhou J; Sun HC; Wang L; Qiu SJ; Ye QH; Fan J
    Surgery; 2014 Sep; 156(3):651-60. PubMed ID: 24998159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
    Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection.
    Zhu Y; Li JH; Yang J; Gao XM; Jia HL; Yang X
    Medicine (Baltimore); 2017 Sep; 96(39):e8056. PubMed ID: 28953624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
    Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation.
    Facciorusso A; Del Prete V; Antonino M; Neve V; Crucinio N; Di Leo A; Carr BI; Barone M
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1905-10. PubMed ID: 24731153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma.
    Uemura M; Sasaki Y; Yamada T; Gotoh K; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
    Ann Surg Oncol; 2014 May; 21(5):1719-25. PubMed ID: 24464342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.
    Li T; Fan J; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY
    Ann Surg Oncol; 2011 Jul; 18(7):1955-63. PubMed ID: 21240562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments.
    Lee IC; Huang YH; Chau GY; Huo TI; Su CW; Wu JC; Lin HC
    Int J Cancer; 2013 Dec; 133(12):2895-902. PubMed ID: 23749461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
    Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
    Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.
    Zhu W; Guo L; Zhang B; Lou L; Lin Z; Zhu X; Ren N; Dong Q; Ye Q; Qin L
    Ann Surg Oncol; 2014 Apr; 21(4):1304-13. PubMed ID: 24366422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection.
    Diao P; Wu Y; Li J; Zhang W; Huang R; Zhou C; Wang Y; Cheng J
    J Transl Med; 2018 Dec; 16(1):365. PubMed ID: 30563540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
    Poon RT; Fan ST; Ng IO; Lo CM; Liu CL; Wong J
    Cancer; 2000 Aug; 89(3):500-7. PubMed ID: 10931448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
    Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 90.